Here are four quick facts:
1. ArthroFuse is a patent-pending allograft designed for the treatment of hammertoe deformities.
2. Current surgical options for hammertoe include screws, staples, pins and intermedulary implants.
3. Bacterin’s new product eliminates the need for externally communicating pins or permanent implants as it is an implant that will remodel over time into the patient’s own bone.
4. Bacterin develops, manufactures and markets biologics products to domestic and international markets.
More articles on devices:
Intelligent Implant Systems receives spine system patent — 5 things to know
Is the Zimmer-Biomet closed merger finally around the corner? 5 things to know
7 trends in the $850M bone graft substitute market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.